Category: Pakistan

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and metabolic medicine, Allianthera (Suzhou) Biopharmaceuticals Co., […]

Read More

Ambiq Announces Pricing of Upsized Initial Public Offering

Ambiq Announces Pricing of Initial Public Offering AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of its common stock at a public offering price of $24.00 per share. […]

Read More

Meltwater Debuts Industry-First GenAI Lens, Unlocking Enhanced Brand Insights

SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, today announces the launch of GenAI Lens, an industry-first, groundbreaking tool that gives companies unprecedented visibility into how their brand, competitors and industry are discussed across all major AI Assistants and LLMs (Large Language Models) including ChatGPT, Claude, Gemini, […]

Read More

Mavenir Completes Comprehensive Recapitalization

Transaction eliminates more than $1.3 billion of existing debt and secures $300 million of new senior financing, meaningfully strengthening Mavenir’s balance sheet. Mavenir well-positioned for sustained growth and long-term success. Siris remains controlling shareholder with support from key existing Mavenir lenders. RICHARDSON, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building […]

Read More